Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Choroid plexus inflammation in bipolar disorder.

Brain, behavior, and immunity·2026
Same author

A patient with a rare metabolic disease and myo-inositol administration leading to a new treatment for epilepsy.

Molecular genetics and metabolism·2026
Same author

The choroid plexus: both a gatekeeper and a conductor of neuroimmune communication.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Temporal and cell-type specific SPAK-NKCC1 disruption following severe TBI in the developing gyrencephalic brain.

Acta neuropathologica communications·2026
Same author

Base barrier cells provide compartmentalization of choroid plexus, brain and CSF.

Nature neuroscience·2026
Same author

Author Correction: Choroid plexus apocrine secretion shapes CSF proteome during mouse brain development.

Nature neuroscience·2026

Related Experiment Video

Updated: Sep 21, 2025

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
09:58

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side

Published on: May 6, 2016

14.4K

Experimental approaches for manipulating choroid plexus epithelial cells.

Ahram Jang1, Maria K Lehtinen2

  • 1Department of Pathology, Boston Children's Hospital, Boston, MA, 02115, USA.

Fluids and Barriers of the CNS
|May 26, 2022
PubMed
Summary
This summary is machine-generated.

Targeting choroid plexus (ChP) epithelial cells offers new therapeutic avenues for brain disorders. This review details methods for manipulating these cells, crucial for the blood-cerebrospinal fluid barrier (BCSFB).

Keywords:
Adeno-associated virus (AAV)Blood-cerebrospinal fluid barrier (BCSFB)Cerebrospinal fluid (CSF)ChemogeneticsChoroid plexus (ChP)Gene therapy

More Related Videos

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

1.1K
Observation of the Ciliary Movement of Choroid Plexus Epithelial Cells Ex Vivo
08:00

Observation of the Ciliary Movement of Choroid Plexus Epithelial Cells Ex Vivo

Published on: July 13, 2015

12.3K

Related Experiment Videos

Last Updated: Sep 21, 2025

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
09:58

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side

Published on: May 6, 2016

14.4K
Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

1.1K
Observation of the Ciliary Movement of Choroid Plexus Epithelial Cells Ex Vivo
08:00

Observation of the Ciliary Movement of Choroid Plexus Epithelial Cells Ex Vivo

Published on: July 13, 2015

12.3K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biotechnology

Background:

  • Choroid plexus (ChP) epithelial cells are vital for the blood-cerebrospinal fluid barrier (BCSFB) and brain homeostasis.
  • The ChP regulates cerebrospinal fluid (CSF) production, secretes neurotrophic factors, and clears waste products like Amyloid beta.
  • Dysfunction of ChP cells is implicated in neurodevelopmental and neurological disorders.

Purpose of the Study:

  • To review current and emerging experimental strategies for targeting ChP epithelial cells.
  • To highlight methods for specific in vivo gain or loss of function studies of ChP cells.
  • To discuss the potential of ChP-targeted therapies for central nervous system (CNS) disorders.

Main Methods:

  • Review of genetic models and viral gene delivery systems for ChP cell manipulation.
  • Analysis of reporter lines for accessing ChP epithelia.
  • Discussion of novel approaches including chemical activation and engineered ChP cell transplantation.

Main Results:

  • Successful and emerging experimental approaches for targeting ChP epithelial cells are detailed.
  • Methodological strategies for specific in vivo gain or loss of function are presented.
  • Various reporter lines and novel therapeutic strategies are reviewed.

Conclusions:

  • Targeting ChP epithelial cells presents a promising strategy for treating CNS disorders.
  • Experimental approaches are paving the way for clinical applications in neurotherapeutics.
  • Understanding ChP function in secretion and clearance is key to developing effective therapies.